Many patients with skin cancer who were treated with immune checkpoint inhibition experienced long-term side effects, although some resolved over time, research showed. Chronic immune-related side effects were common in patients with skin cancer who were treated with postsurgical Opdivo…
First late effects study since new treatments were introduced found high prevalence of hearing loss, growth failure, underweight and lung disease Globally, neuroblastoma accounts for 8–10 percent of childhood cancers. It is generally diagnosed at a median age of 17–18 months, with…
From these early results, the researchers believe that overactive platelets likely drive disease progression and could be an overlooked target for improving the body’s immune response to glioblastoma and other types of tumors. They also believe that hormones likely regulate…
New sites in the UK, France, Sweden, Germany, Italy and Spain will add to the global footprint of the pivotal SIGMA study Study site locations will be listed on ClinicalTrials.gov and updated as finalized. In August 2026, the FDA granted…
(L to R) Qianqian Li, PhD; Dana Farmer, PhD; first author Justin Williams, PhD; corresponding author Martine Roussel, PhD, all of St. Jude Department of Tumor Cell Biology, and Jake Friske, PhD, St. Jude Graduate School of Biomedical Sciences Pediatric brain…
At the same time, antibody based therapies— despite their success in peripheral tumors— largely fail to access the brain parenchyma at therapeutically relevant levels. This disconnect has driven an urgent need for new BBB transport routes that are both selective…
WSW, NY, October 19th, 2026, FinanceWire FDA clearance doubles REGAIN’s permitted enrollment and broadens its clinical assessments, as Alpha Tau prepares to present updated results in November. A difficult cancer leaves little room for conventional treatment Alpha Tau is testing precisely that…
An experimental drug that Genmab gained in an $8 billion buyout succeeded in a late-stage trial in a form of head and neck cancer, sending shares of the Danish drugmaker soaring to an all-time high. At an early analysis, a combination…
Residual pigmentation after primary treatment and nonbulbar tumor involvement were associated with higher local recurrence risk, while ulceration and greater tumor thickness were linked to metastasis... Review of: Conjunctival melanocytic lesions: A practical sequential treatment approach Mastrogiuseppe E, Hussain R,…
NEW DELHI: Tackling tobacco dependence through sustained cessation support, alongside controlling high blood pressure, is crucial to reducing India's stroke burden, experts said on the eve of World Stroke Day, calling for a stronger public-health response that goes beyond awareness…
Melanoma and skin cancer, brain tumours, head and neck and thyroid cancer, sarcomas and rarer cancers.
An article joins this feed when it matches these terms. Each one is also a search of its own.